Rapport Therapeutics, Inc.

RAPP chart

Rapport Therapeutics, Inc. news

• How Rapport Therapeutics Inc. (RAPP) Affects Rotational Strategy Timing

  Stock Traders Daily · Oct 26, 10:30 PM EDT

• Rapport Therapeutics, Inc. (RAPP) Stock Price, News, Quote & History

  Yahoo Finance · Oct 26, 11:44 AM EDT

• Rapport Therapeutics’ RAP-219 Hits Phase II Goals in Bipolar Mania Trial

  marketbeat.com · Oct 25, 1:02 PM EDT

• RAPP Form 4 Filings - Rapport Therapeutics, Inc. SEC Form 4

  Stock Titan · Oct 25, 2:29 AM EDT

• How Positive Phase 2 Mania Data Will Impact Rapport Therapeutics Stock

  Simply Wall Street · Oct 24, 10:56 AM EDT

• Rapport Therapeutics, Inc. (RAPP) Company Profile & Facts

  Yahoo! Finance Canada · Oct 23, 4:00 PM EDT

• RAPP Stock Price and Chart — NASDAQ:RAPP

  TradingView · Oct 23, 1:13 PM EDT

• Rapport Therapeutics (RAPP) Could Be 62% Below Fair Value Following Phase 2 Mania Data

  Yahoo Finance · Oct 23, 4:11 AM EDT

• Rapport Therapeutics director Wendy Young buys $99,991 in shares

  Investing.com · Oct 22, 9:13 PM EDT

• Rapport Therapeutics director John Maraganore acquires $248,891 in stock

  Investing.com · Oct 22, 9:12 PM EDT

• Rapport Therapeutics director Paul Silva buys $99,636 in stock

  Investing.com · Oct 22, 9:11 PM EDT

• Form 4 Rapport Therapeutics Inc: Wendy B. Young (Director) For: 22 October

  Investing.com Nigeria · Oct 22, 9:04 PM EDT

Rapport Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-20
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-06-10
• 10-Q10-Q2026-05-07
• 8-K8-K2026-05-07
• DEF 14ADEF 14A2026-04-23
• 8-K8-K2026-04-21
• 10-K10-K2026-03-10
• 8-K8-K2026-03-10
• 8-K8-K2026-01-07
• 8-K8-K2026-01-07

About Rapport Therapeutics, Inc.

Ticker

RAPP (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2012593

Former names

Rapport Therapeutics, Inc.

Frequently asked questions